source
- Biotech confidence surges in 2026 as China leads growth and deal activity spikesIndustry observers noted a marked shift in tone at two major 2026 biotech gatherings – the DIA China meeting in Shanghai and the BIO International Convention in San Diego – where participants expre…
- Argenx to acquire Forte Biosciences for $2.2 billion, bolstering its autoimmune drug pipelineArgenx announced it will purchase Dallas-based Forte Biosciences for $2.2 billion in cash. The transaction values Forte at $77 per share, a 41 percent premium to its closing price on Friday. The a…